2017
DOI: 10.1016/j.ejmech.2017.05.019
|View full text |Cite
|
Sign up to set email alerts
|

Discorhabdin alkaloids from Antarctic Latrunculia spp. sponges as a new class of cholinesterase inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
31
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 33 publications
(33 citation statements)
references
References 40 publications
2
31
0
Order By: Relevance
“…481 A joint HR-ESI-MS study in conjunction with data mining of published bioactivity data has allowed a comprehensive analysis of the SAR related to the discorhabdin alkaloid family to predict the most important components of the pharmacophore; 482 additionally several discorhabdin congeners have been shown to be reversible inhibitors of various cholinesterases and hence may have potential as treatments for Alzheimer's disease. 483 The treatment of pain and epilepsy are potential outcomes from the discovery that oroidin-type alkaloids are modulators of the K v 1 subfamily of voltage gated potassium ion channels. 484 The merosesquiterpenoid metachromin A has been found to have nanomolar antiviral activity against hepatitis B via impairment of viral promoter activity, 485 while several furanoditerpenoids are new protein tyrosine phosphatase 1B inhibitors.…”
Section: Spongesmentioning
confidence: 99%
“…481 A joint HR-ESI-MS study in conjunction with data mining of published bioactivity data has allowed a comprehensive analysis of the SAR related to the discorhabdin alkaloid family to predict the most important components of the pharmacophore; 482 additionally several discorhabdin congeners have been shown to be reversible inhibitors of various cholinesterases and hence may have potential as treatments for Alzheimer's disease. 483 The treatment of pain and epilepsy are potential outcomes from the discovery that oroidin-type alkaloids are modulators of the K v 1 subfamily of voltage gated potassium ion channels. 484 The merosesquiterpenoid metachromin A has been found to have nanomolar antiviral activity against hepatitis B via impairment of viral promoter activity, 485 while several furanoditerpenoids are new protein tyrosine phosphatase 1B inhibitors.…”
Section: Spongesmentioning
confidence: 99%
“…While results are still scarce emerging evidence indicates that North-Atlantic (Jackson et al, 2013;Kennedy et al, 2014) or Antarctic (Webster et al, 2004;Xin et al, 2011;Rodríguez-Marconi et al, 2015) cold-and/or deep-water sponges harbor diverse prokaryotic communities. Moreover, deep-sea sponges from the Atlantic exhibited novel secondary metabolite synthetic gene clusters of potential prokaryotic origin (Borchert et al, 2016), and Antarctic deep-water sponges proved to be rich sources of bioactive natural compounds (Turk et al, 2013;Berne et al, 2016;Botić et al, 2017;Angulo-Preckler et al, 2018;Mangano et al, 2018). Consequently, further studies on sponge-microbe associations from rarely accessed environments, such as the Antarctic shelf have the potential to lead to the discovery of novel metabolic mechanisms and bioactive natural compounds for a vast range of biotechnological applications (Sipkema, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Molecular docking has been the major SB methodology to predict affinities to macromolecular targets, to interpret binding modes, and to assist in the design of drug leads. Several recent publications illustrate the application of the method to MNPs [ 127 , 128 , 129 , 138 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 ], and some representative examples are here described.…”
Section: Computer-aided Drug Design (Cadd)mentioning
confidence: 99%